Robotic Companion Pets, Compared
Quick answer: This is a genuinely different category from everything else on this site: a robotic companion pet is the pet, not a device that helps you care for a real one. Three real, distinct options: Tombot Jennie (~$1,500, waitlist, first shipments targeted for late 2026) is a stationary lap-companion robot puppy built with Jim Henson's Creature Shop specifically for seniors and people with dementia; Sony Aibo (~$3,000) is a mobile, interactive robot dog with more autonomous behavior, though Sony announced in mid-2026 that Japanese sales of this generation are ending; PARO (a robotic therapeutic seal) is medical-grade, used clinically in dementia and therapy settings rather than sold as a general consumer companion. These serve a real purpose but aren't a substitute for or supplement to the real-pet tech covered elsewhere on this site.
Everything else on this site is tech that supports caring for a real, living pet. Robotic companion pets are a different thing entirely: the robot is the companion, most commonly built for seniors or people with dementia who benefit from animal-like companionship without the physical care demands of a real pet.
Tombot Jennie: a stationary, therapy-grade lap companion
Tombot Jennie is a robot designed to look and feel like a Labrador puppy, developed with Jim Henson’s Creature Shop — the same studio behind the Muppets’ animatronics expertise. It’s deliberately stationary, built as a lap companion rather than a robot that moves independently around a room, a design choice specifically made for seniors, including people with dementia, who couldn’t safely manage or track a mobile robot. It reacts to touch across its fur, moves its head, tail, and body, and responds to voice commands with real recorded puppy sounds rather than synthesized ones. Priced around $1,500, it’s currently available only via waitlist, with first shipments targeted for late 2026 — you can’t buy one outright today.
Sony Aibo: mobile and interactive, but winding down
Sony Aibo takes a different approach — a mobile, autonomous robot dog priced around $3,000 that develops what Sony describes as a unique character over time, learning to respond to commands and interact more like an actual pet than a stationary comfort object. Worth knowing before considering it: Sony announced in mid-2026 that Japanese sales of this generation of Aibo are ending, putting this specific version in its final sales window. Check current availability directly, including whether this affects sales outside Japan, given the announced wind-down.
PARO: a genuinely different, clinical-grade category
PARO, a robotic therapeutic seal, occupies a meaningfully different tier than the two consumer products above — it’s used clinically in dementia care and therapy settings as a medical-grade tool, with a different evidence base and regulatory context than a general consumer companion product. If you’re evaluating this category for a specific medical or clinical care situation rather than general companionship, that distinction is worth taking seriously rather than treating all three options as interchangeable.
Why this is a genuinely separate category from the rest of this site
This is worth stating directly: nothing else on this site is about replacing or substituting for a real pet — it’s all built around tech that supports caring for one. A robotic companion pet is a different kind of decision entirely, usually made for a specific person’s situation (a senior who can no longer safely care for a live animal, someone with dementia who benefits from animal-like interaction without the responsibilities of actual pet ownership). It’s not something to add on top of an existing real-pet tech setup, and evaluating it belongs in its own context, separate from anything else covered here.
Bottom line
Three real, distinct options exist in this space today: Tombot Jennie for a stationary, therapy-grade lap companion (waitlist, late 2026 shipping); Sony Aibo for a more autonomous, interactive robot, though this generation is in its final sales window per Sony’s own announcement; and PARO for an actual clinical-grade therapeutic tool rather than a general consumer product. None of these are pet tech in the sense the rest of this site covers — they’re a different category of decision, worth researching on its own terms for the specific person and situation involved. If the reason you’re considering this is a caregiving situation for someone with cognitive decline specifically, see our cognitive accessibility guide for the broader context this option fits into.
Frequently asked questions
What is Tombot Jennie, specifically?
A therapy robot designed to look and feel like a Labrador puppy, developed with Jim Henson's Creature Shop, built as a lap companion — it doesn't move around a room independently, which is a deliberate design choice for seniors, including people with dementia, who couldn't safely manage a mobile robot. It reacts to touch across its fur, moves its head, tail, and body, and responds to voice with real recorded puppy sounds. It's priced around $1,500, currently only available via waitlist, with first shipments targeted for late 2026.
Is Sony Aibo still available?
Not indefinitely — Sony announced in mid-2026 that Japanese sales of this generation of Aibo are ending, meaning this specific version is in its final sales window. Aibo has been the more autonomous, mobile option in this category (roughly $3,000), developing what Sony describes as a unique character over time and responding to commands more like an actual interactive pet than a stationary companion. Availability going forward, including outside Japan, is worth checking directly given this announced wind-down.
What's the difference between these and a medical-grade therapeutic robot like PARO?
A real, meaningful distinction. PARO (a robotic seal) is used clinically in dementia care and therapy settings as a medical-grade tool, with a different regulatory and evidence bar than a consumer companion product. Tombot Jennie and Sony Aibo are consumer products aimed at companionship and comfort more broadly; PARO occupies a more clinical, evidence-based therapeutic role. If you're evaluating this category for a specific medical or care context (a loved one with dementia, for instance), that distinction is worth taking seriously rather than treating all three as interchangeable options.
Does this site cover robotic companion pets as an alternative to a real pet?
Only in this narrow, distinct sense — this is a genuinely different category from everything else on this site, which is built around tech that supports care for a real, living pet. A robotic companion is the pet itself, not a device you'd add to an existing pet's setup. If you're researching this for a senior or a person with dementia specifically, treat it as its own decision, separate from anything else this site covers.